Who owns Sensei Biotherapeutics Inc?
- Ticker: SNSE
- CUSIP Number: 81728a207
Tip: Access positions for across all investors
Analyze quarterly positions in Sensei Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sensei Biotherapeutics stock
Who bought or sold Sensei Biotherapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 23k | $213k | 0% | Sep 2025 |
|
| Catalio Capital Management | 15k | $139k | 100% | Sep 2025 |
|
| Renaissance Technologies | 10k | $98k | 100% | Sep 2025 |
|
| UBS Group | 873.00 | $8.3k | -59% | Sep 2025 |
|
| SBI Securities | 149.00 | $1.4k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 32.00 | $302.000000 | 100% | Sep 2025 |
|
| Morgan Stanley | 10.00 | $86.000000 | 100% | Jun 2025 |
|
| Bnp Paribas Arbitrage, Snc | 9.00 | $84.999600 | 0% | Sep 2025 |
|
Who sold out of Sensei Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Jun 2025 | 29k | $250k |
| NWF Advisory Services | Mar 2025 | 17k | $6.5k |
| Raymond James Financial | Jun 2025 | 700.00 | $6.0k |